News articles about Cognex (NASDAQ:CGNX) have trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cognex earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave media coverage about the scientific and technical instruments company an impact score of 46.5729544294185 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news headlines that may have effected Accern Sentiment’s scoring:

Cognex (NASDAQ:CGNX) traded down $3.03 during trading on Monday, hitting $55.77. Cognex has a 12-month low of $36.67 and a 12-month high of $72.99. The company has a market cap of $9,660.00, a price-to-earnings ratio of 56.91 and a beta of 1.44.

Cognex (NASDAQ:CGNX) last released its quarterly earnings data on Thursday, February 15th. The scientific and technical instruments company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.25 by $0.05. Cognex had a net margin of 23.69% and a return on equity of 24.23%. The business had revenue of $180.37 million for the quarter, compared to analyst estimates of $178.75 million. During the same period in the previous year, the firm earned $0.20 EPS. The business’s revenue for the quarter was up 39.5% compared to the same quarter last year. analysts forecast that Cognex will post 1.48 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 16th. Investors of record on Friday, March 2nd will be given a $0.045 dividend. The ex-dividend date of this dividend is Thursday, March 1st. This represents a $0.18 annualized dividend and a dividend yield of 0.32%. Cognex’s dividend payout ratio is presently 18.37%.

Cognex announced that its board has approved a stock repurchase program on Thursday, February 15th that allows the company to repurchase $150.00 million in outstanding shares. This repurchase authorization allows the scientific and technical instruments company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

A number of equities analysts have recently weighed in on CGNX shares. ValuEngine cut shares of Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Canaccord Genuity upped their price target on shares of Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research note on Tuesday, October 31st. BidaskClub raised shares of Cognex from a “hold” rating to a “buy” rating in a research note on Wednesday, January 10th. Zacks Investment Research upgraded shares of Cognex from a “hold” rating to a “buy” rating and set a $69.00 price objective on the stock in a research report on Wednesday, November 1st. Finally, Robert W. Baird boosted their price objective on shares of Cognex from $50.00 to $62.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 31st. Three research analysts have rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $66.83.

In related news, Director Patrick Alias sold 5,000 shares of the business’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $143.54, for a total value of $717,700.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. 5.60% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Cognex (CGNX) Receiving Somewhat Favorable Press Coverage, Analysis Shows” was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at

Cognex Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with's FREE daily email newsletter.